L

Labiana Health SA
MAD:LAB

Watchlist Manager
Labiana Health SA
MAD:LAB
Watchlist
Price: 3.6 EUR -1.64% Market Closed
Market Cap: 26m EUR

Net Margin
Labiana Health SA

0.4%
Current
-3%
Average
5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0.4%
=
Net Income
253.5k
/
Revenue
66.3m

Net Margin Across Competitors

Country Company Market Cap Net
Margin
ES
Labiana Health SA
MAD:LAB
24.9m EUR
0%
US
Eli Lilly and Co
NYSE:LLY
722.9B USD
23%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
US
Johnson & Johnson
NYSE:JNJ
360.3B USD
24%
DK
Novo Nordisk A/S
CSE:NOVO B
2.1T DKK
35%
CH
Roche Holding AG
SIX:ROG
206.2B CHF
14%
CH
Novartis AG
SIX:NOVN
185.9B CHF
24%
UK
AstraZeneca PLC
LSE:AZN
161.1B GBP
14%
US
Merck & Co Inc
NYSE:MRK
198.9B USD
27%
IE
Endo International PLC
LSE:0Y5F
163.5B USD
-126%
US
Pfizer Inc
NYSE:PFE
136.3B USD
13%

Labiana Health SA
Glance View

Market Cap
24.9m EUR
Industry
Pharmaceuticals

Labiana Health SA manufactures sterile and lyophilized dosage forms. The company is headquartered in Pozuelo De Alarcon, Madrid and currently employs 477 full-time employees. The company went IPO on 2022-06-24. The Firm, through its subsidiaries, is engaged in the development, manufacturing and marketing of animal and human medicines. The Company’s main activities are: Drug research and development (R&D), which includes galenic and analytical development; Drug manufacturing, which focuses on formulation development, formulation optimization, bacterial vaccine manufacturing, among others; Regulatory services, which carries out registration procedures for pharmaceutical products in world markets. The Company, through its subsidiaries, is present in Ecuador, Mexico, Serbia and Turkey.

LAB Intrinsic Value
9.39 EUR
Undervaluation 62%
Intrinsic Value
Price
L
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0.4%
=
Net Income
253.5k
/
Revenue
66.3m
What is the Net Margin of Labiana Health SA?

Based on Labiana Health SA's most recent financial statements, the company has Net Margin of 0.4%.

Back to Top